ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc (ENTA)

6,60
-0,17
( -2,51% )
Aktualisiert: 15:31:47

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
6,60
Gebot
6,57
Fragen
6,63
Volumen
35.273
6,58 Tagesbereich 6,91
4,71 52-Wochen-Bereich 17,80
Marktkapitalisierung
Handelsende
6,77
Handelsbeginn
6,91
Letzte Trade
11
@
6.6
Letzter Handelszeitpunkt
15:31:23
Finanzvolumen
US$ 236.302
VWAP
6,6992
Durchschnittliches Volumen (3 Mio.)
563.388
Ausgegebene Aktien
21.332.544
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,24
Gewinn pro Aktie (EPS)
-5,44
Erlöse
67,64M
Nettogewinn
-116,05M

Über Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of... Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Enanta Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENTA. The last closing price for Enanta Pharmaceuticals was US$6,77. Over the last year, Enanta Pharmaceuticals shares have traded in a share price range of US$ 4,71 to US$ 17,80.

Enanta Pharmaceuticals currently has 21.332.544 shares in issue. The market capitalisation of Enanta Pharmaceuticals is US$144,42 million. Enanta Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.24.

ENTA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.63-8.713692946067.237.496.492675307.08892492CS
41.2122.44897959185.398.765.23085379067.44495554CS
120.447.142857142866.168.764.715633886.11707118CS
26-5.41-45.045795170712.0113.134.713844387.29702295CS
52-8.8-57.142857142915.417.84.712795869.45203007CS
156-58.41-89.84771573665.0179.4954.7126059623.73019931CS
260-45.47-87.324755137352.071024.7122350633.37057114CS

ENTA - Frequently Asked Questions (FAQ)

What is the current Enanta Pharmaceuticals share price?
The current share price of Enanta Pharmaceuticals is US$ 6,60
How many Enanta Pharmaceuticals shares are in issue?
Enanta Pharmaceuticals has 21.332.544 shares in issue
What is the market cap of Enanta Pharmaceuticals?
The market capitalisation of Enanta Pharmaceuticals is USD 144,42M
What is the 1 year trading range for Enanta Pharmaceuticals share price?
Enanta Pharmaceuticals has traded in the range of US$ 4,71 to US$ 17,80 during the past year
What is the PE ratio of Enanta Pharmaceuticals?
The price to earnings ratio of Enanta Pharmaceuticals is -1,24
What is the cash to sales ratio of Enanta Pharmaceuticals?
The cash to sales ratio of Enanta Pharmaceuticals is 2,14
What is the reporting currency for Enanta Pharmaceuticals?
Enanta Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Enanta Pharmaceuticals?
The latest annual turnover of Enanta Pharmaceuticals is USD 67,64M
What is the latest annual profit for Enanta Pharmaceuticals?
The latest annual profit of Enanta Pharmaceuticals is USD -116,05M
What is the registered address of Enanta Pharmaceuticals?
The registered address for Enanta Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Enanta Pharmaceuticals website address?
The website address for Enanta Pharmaceuticals is www.enanta.com
Which industry sector does Enanta Pharmaceuticals operate in?
Enanta Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SYRSSyros Pharmaceuticals Inc
US$ 0,2723
(197,27%)
403,45M
RAYRaytech Holding Ltd
US$ 1,71
(96,55%)
10,25M
TSVT2seventy bio Inc
US$ 4,9203
(75,73%)
21,57M
CUTRCutera Inc
US$ 0,1936
(50,66%)
131,71M
HSAIHesai Group
US$ 22,6794
(41,66%)
12,82M
ARVNArvinas Inc
US$ 8,35
(-52,45%)
5,99M
LZMHLZ Technology Holdings Ltd
US$ 8,3637
(-46,59%)
214,9k
SPGCSacks Parente Golf Inc
US$ 0,1128
(-29,54%)
17,41M
XAGELongevity Health Holdings Inc
US$ 0,2274
(-28,94%)
1,58M
BDRXBiodexa Pharmaceuticals PLC
US$ 2,09
(-26,67%)
408,7k
SYRSSyros Pharmaceuticals Inc
US$ 0,272673
(197,68%)
403,45M
AWHAspira Womans Health Inc
US$ 0,2731
(37,93%)
148,85M
CUTRCutera Inc
US$ 0,1936
(50,66%)
131,71M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,655
(3,73%)
113,63M
NVDANVIDIA Corporation
US$ 107,465
(0,45%)
84,58M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht